SRSF2 rs1057518401: Understanding This Rare Genetic Variant
The rs1057518401 variant is a rare duplication mutation located within the SRSF2 gene. It is currently classified as probable-pathogenic in clinical databases, reflecting its potential impact on biological processes.
What each genotype means
Heterozygous carrier status
This genotype indicates the presence of one copy of the duplication mutation. While this variant is classified as probable-pathogenic in clinical databases, its specific clinical significance for an individual without symptoms is not fully established; please consult with a genetic counselor or clinician to discuss these findings.
This genotype is rare in the general population.
Homozygous variant status
This genotype indicates the presence of two copies of the duplication mutation. This variant is classified as probable-pathogenic, and you should discuss the implications of this result with a medical professional or genetic specialist to understand its relevance to your health.
This genotype is extremely rare in the general population.
What is rs1057518401?
The variant rs1057518401 is a specific genetic alteration characterized as a duplication mutation. In genetic terms, a duplication involves the repetition of a segment of DNA sequence. This particular variant is situated on chromosome 17 and involves the SRSF2 gene, which is also known as serine and arginine rich splicing factor 2. Because it is a duplication rather than a simple single-nucleotide change, it can potentially alter the reading frame or the structural integrity of the resulting protein. Clinical databases currently categorize this variant as probable-pathogenic, a designation used when there is significant evidence suggesting the variant may contribute to health-related conditions, though it is not always definitive. It is important to note that genetic variants are identified by their specific location and the nature of the change, and this record serves as a reference for researchers and clinicians studying the human genome.
The Role of the SRSF2 Gene
The SRSF2 gene provides instructions for creating a protein that is a member of the SR protein family. This protein plays a critical role in mRNA splicing, a fundamental biological process where non-coding segments of RNA are removed and coding segments are joined together to create a mature template for protein production. Beyond its role in constitutive and alternative splicing, the SRSF2 protein is involved in mRNA export from the cell nucleus and in the translation process. Because splicing is essential for the proper expression of many genes, the function of SRSF2 is vital for cellular health. Research has shown that SRSF2 is particularly important during processes like spermatogenesis. When the function of this gene is disrupted, it can lead to aberrant splicing, where the cell produces incorrect versions of proteins, which may interfere with normal cellular operations and contribute to various disease states.
Research and Clinical Associations
Scientific research has extensively studied mutations within the SRSF2 gene, particularly in the context of hematologic conditions such as myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). While many well-known SRSF2 mutations are missense mutations—such as those at the 95th proline residue—the rs1057518401 duplication is a distinct variant. The evidence strength for this specific variant is currently considered moderate. Studies on SRSF2 mutations generally suggest that they can act as 'gain-of-function' mutations, altering the binding properties of the protein to RNA motifs and causing widespread splicing errors. These errors can affect the stability and translation of other genes, potentially driving disease progression or resistance to certain therapies. Because the evidence for this specific duplication is evolving, it is categorized as probable-pathogenic, meaning that while it is flagged for clinical attention, ongoing research is required to fully map its specific functional consequences and clinical impact.
Population Frequency and Interpretation
The rs1057518401 variant is classified as rare across human populations. In genetics, 'rare' typically indicates that the variant is not found in a significant percentage of the general population, making it an uncommon finding in standard genomic screening. Because of its rarity, large-scale population studies have limited data on its distribution across different ancestral groups. When a variant is rare and classified as probable-pathogenic, it is often identified in clinical settings where individuals are being tested for specific symptoms or conditions. It is crucial for readers to understand that the presence of a rare variant does not automatically imply a diagnosis. Genetic information is complex, and the clinical significance of any variant must be interpreted by a qualified healthcare professional who can consider the individual's full medical history, family background, and other genetic factors. This information should be used for educational purposes and to facilitate informed discussions with a medical provider.
What You Can Do With This Information
If you have received information regarding the rs1057518401 variant, the most important step is to consult with a genetic counselor or a physician. Genetic data is highly nuanced, and a professional can help you understand what this result means in the context of your personal health. You cannot use this information to self-diagnose or predict future health outcomes. If this variant is discussed in the context of medication response or treatment, it is essential to discuss any potential implications for dosing or therapy with your clinician or pharmacist. They are the only ones qualified to make medical decisions based on your genetic profile. Avoid making changes to your health regimen based solely on online information. Instead, use this knowledge to prepare questions for your next medical appointment, ensuring that you and your healthcare team are working from the most accurate and relevant information available.
How common is this variant?
The rs1057518401 variant is considered rare across all studied human populations.
Frequently asked questions
What does 'probable-pathogenic' mean for this variant?
Probable-pathogenic means that there is significant evidence suggesting the variant may be associated with a health condition, but the evidence is not yet considered definitive. It serves as a signal for clinicians to investigate further in the context of a patient's specific symptoms.
Is this variant a cause of leukemia?
While mutations in the SRSF2 gene are frequently observed in conditions like myelodysplastic syndromes and acute myeloid leukemia, this specific variant is a rare duplication. You should discuss any concerns about cancer risk with a medical professional who can evaluate your specific clinical situation.
Should I be worried if I have this variant?
Finding a rare variant does not mean you have a disease or will develop one. Genetic results should always be interpreted by a healthcare provider who can look at your entire health picture and provide appropriate guidance.
Where can I find more information about SRSF2?
You can find reliable information about the SRSF2 gene and its functions through resources like the NCBI Gene database or MedlinePlus Genetics. These sites provide comprehensive summaries of gene function and their roles in human health.
Sources & further reading
Educational information only, last refreshed 10/11/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1057518401?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29